Response by Cavender et al to Letter Regarding Article, "Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX"

Affiliations

¹ Department of Medicine, University of North Carolina, Chapel Hill (M.A.C.).
² Department of Medicine, Stanford University, CA (R.A.H.).
³ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.L.B.).

Comment

Matthew A Cavender et al. Circ Cardiovasc Interv. 2022 Jul.

. 2022 Jul;15(7):e012222.

doi: 10.1161/CIRCINTERVENTIONS.122.012222. Epub 2022 Jul 19.

¹ Department of Medicine, University of North Carolina, Chapel Hill (M.A.C.).
² Department of Medicine, Stanford University, CA (R.A.H.).
³ Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (D.L.B.).

No abstract available

Comment on

Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX.
Cavender MA, Harrington RA, Stone GW, Steg PG, Gibson CM, Hamm CW, Price MJ, Lopes RD, Leonardi S, Deliargyris EN, Prats J, Mahaffey KW, White HD, Bhatt DL; CHAMPION PHOENIX Investigators*. Cavender MA, et al. Circ Cardiovasc Interv. 2022 Jan;15(1):e010390. doi: 10.1161/CIRCINTERVENTIONS.120.010390. Epub 2021 Dec 17. Circ Cardiovasc Interv. 2022. PMID: 34915723 Free PMC article. Clinical Trial.
Letter by Zaghloul et al Regarding Article, "Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX".
Zaghloul S, Patel N, Ahmad M. Zaghloul S, et al. Circ Cardiovasc Interv. 2022 Jul;15(7):e012098. doi: 10.1161/CIRCINTERVENTIONS.122.012098. Epub 2022 Jul 19. Circ Cardiovasc Interv. 2022. PMID: 35861799 No abstract available.